21:42:35 EDT Thu 03 Oct 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:ORGO - ORGANOGENESIS HOLDINGS INC - https://organogenesis.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ORGO - Q0.12.52·3.110.32.86+0.010.4246.06291,3682.82  2.865  2.814.705  1.9616:29:48Oct 0115 min RT 2¢

Recent Trades - Last 10 of 1368
Time ETExPriceChangeVolume
16:29:48Q2.860.013,720
16:02:52Q2.860.011,558
16:02:42Q2.860.01202
16:02:20Q2.860.012,926
16:00:06Q2.860.0173,067
16:00:02Q2.860.011,493
16:00:01Q2.860.01363
16:00:01Q2.860.01563
16:00:01Q2.860.01100
16:00:01Q2.860.011,978

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-10-01 16:05U:ORGONews ReleaseOrganogenesis Announces Publication of Randomized Clinical Trial Results Demonstrating the Safety and Efficacy of NuShield for Diabetic Foot Ulcers
2024-09-04 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
2024-08-08 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. Reports Second Quarter 2024 Financial Results
2024-08-08 16:04U:ORGONews ReleaseOrganogenesis Shares ReNu(TM) Program Update
2024-07-15 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024
2024-06-06 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
2024-05-09 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. Reports First Quarter 2024 Financial Results
2024-05-02 07:00U:ORGONews ReleaseOrganogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu(TM) for Knee Osteoarthritis
2024-04-16 07:30U:ORGONews ReleaseOrganogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
2024-04-03 07:30U:ORGONews ReleaseOrganogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
2024-02-29 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
2024-02-12 07:30U:ORGONews ReleaseOrganogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
2024-02-08 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
2023-11-09 16:05U:ORGONews ReleaseOrganogenesis Holdings Inc. Reports Third Quarter 2023 Financial Results
2023-10-05 07:30U:ORGONews ReleaseOrganogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023